Welcome to our dedicated page for Health In Tech SEC filings (Ticker: HIT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Health In Tech, Inc. filings document material-event disclosures for a Nevada operating company with Class A common stock listed on the Nasdaq Capital Market under HIT. Recent Form 8-K reports cover results of operations and financial condition, Regulation FD materials, investor presentations and conference-call transcripts.
The filing record also addresses capital-structure matters, including a private investment in public equity financing, and governance disclosures involving executive officer departures, compensatory arrangements and related consulting agreements. The company identifies as an emerging growth company in its Exchange Act reports.
Health In Tech, Inc. reported that Chief Growth Officer Hasan Zain Syed surrendered 4,084 shares of Class A Common Stock on July 15, 2026 to the company to satisfy tax withholding obligations related to vesting of restricted stock. The shares were valued at $1.04 each. After this tax-withholding disposition, Syed directly holds 204,218 Class A shares, including 189,249 restricted and 14,969 unrestricted shares.
Health In Tech, Inc. reports that CEO Tim Donald Johnson had 47,217 Class A Common shares withheld at $1.04 per share to satisfy tax obligations tied to vesting restricted stock. After this tax-withholding disposition, he directly holds 23,380,692 Class A shares, including 911,932 restricted and 22,468,760 unrestricted shares; this excludes Class B shares and options.
Health In Tech, Inc. director and Chief Financial Officer Qian LinLin surrendered 28,725 Class A Common shares on July 15, 2026 to the issuer to satisfy tax withholding tied to vesting of restricted stock. After this, LinLin directly owns 9,026,575 Class A shares, including 984,340 restricted and 8,042,235 unrestricted, and also holds 2,700,000 Class B shares and 711,510 options that are excluded from this Class A total.
Shrestha Sanjay K reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Sanjay K. Shrestha received a grant of 18,867 restricted shares of Class A Common Stock on July 8, 2026 under the Health in Tech Equity Incentive Plan. The restricted stock vested as of the grant date, and his direct holdings increased to 101,200 shares following this award.
Howard William D. reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Howard William D. received a grant of 18,867 restricted shares of Class A Common Stock on July 8, 2026 under the Health in Tech Equity Incentive Plan. The grant is reported at $1.06 per share, and his direct holdings after the award total 138,510 shares. The restricted stock vested as of the grant date.
Hayes Timothy reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Hayes Timothy received a grant of 18,867 restricted shares of Class A Common Stock at $1.06 per share under the Health in Tech Equity Incentive Plan. The restricted stock vested as of the grant date, bringing his direct holdings to 138,510 shares.
Health In Tech, Inc. amends its Form S-3 shelf registration to offer up to $300,000,000 of securities, subject to a Baby Shelf Limitation. The shelf permits sales of common stock, preferred stock, warrants, debt, subscription rights and units in one or more offerings; specific terms will be set forth in prospectus supplements.
The prospectus states the company had a public float of approximately $32.3 million based on 53,858,083 shares of Class A Common Stock outstanding and a referenced price of $1.57 per share as of May 7, 2026. The filing notes an aggregate offering cap of $300,000,000 and discloses plan to use proceeds for general corporate purposes.
Health In Tech, Inc. has filed a prospectus to register for resale up to 5,600,000 shares of Class A Common Stock acquired by selling stockholders in a PIPE offering. The company will receive no proceeds from these resales; the selling stockholders will receive all proceeds. Shares outstanding were 53,842,109 as of May 21, 2026. The prospectus states the resale shares may be sold from time to time through underwriters, brokers, dealers or directly, and that sales could occur at prevailing or negotiated prices. The company disclosed the PIPE closed on March 27, 2026 and generated gross proceeds of $7.0 million to the company. The filing lists representative selling holders and shows per‑holder examples including holdings of 800,000, 800,000 and 2,400,000 shares for named holders. The registration is being filed pursuant to a registration rights agreement and will remain effective until the registered shares can be resold without restrictions or all registered shares are sold.
Health In Tech, Inc. Chief Growth Officer Hasan Zain Syed reported a routine tax-related share disposition. On the vesting of previously granted restricted Class A Common Stock, he surrendered 4,045 shares at $1.05 per share to cover tax withholding and remittance obligations. After this transaction, he directly holds 208,302 Class A shares, including 199,288 restricted and 9,014 unrestricted shares. This was not an open-market sale but a compensation-related tax withholding event.